DOSING
VILTEPSO is a weight-based infusion medication for amenable Duchenne patients
VILTEPSO is given as an 80-mg/kg weekly intravenous infusion
The appropriate dose of VILTEPSO is calculated based upon the patient’s weight
VILTEPSO is infused for 60 minutes by a healthcare professional, either at the patient’s home or at a treatment center
LETTER OF MEDICAL NECESSITY TOOL
Ready to prescribe VILTEPSO? Our Letter of Medical Necessity tool can help.
HOW TO DOSE AND ADMINISTER A VILTEPSO INFUSION
Determining dosing for VILTEPSO infusion
VILTEPSO is available as single-dose vials containing 250 mg/5 mL (50 mg/mL) solution. The appropriate dose is based on patient’s body weight, with the recommended dosage of VILTEPSO 80 mg/kg administered once weekly as a 60-minute intravenous infusion. There are no age restrictions for VILTEPSO.
Weekly dosing chart
Odd-numbered body weights (in kg) are shown for illustrative purposes only.
*
If volume of VILTEPSO required is <100 mL, dilution in 0.9% sodium chloride for injection, USP, is required such that the total volume in the infusion bag is 100 mL. If the volume of VILTEPSO to be infused is ≥100 mL, dilution is not required.
†
The actual number of theoretical vials required is 15.04.
When less than 100 mL of VILTEPSO is required:
1.
Withdraw from the 100‑mL infusion bag a volume of 0.9% sodium chloride for injection, USP, equivalent to the calculated volume of VILTEPSO solution that will be added.
2.
Withdraw the calculated volume of VILTEPSO solution from the appropriate number of vials, and inject into the infusion bag, such that the total volume in the bag is 100 mL.
When 100 mL or more of VILTEPSO is required:
Withdraw the calculated volume of VILTEPSO solution from the appropriate number of vials, and inject into an empty infusion bag. Further dilution is not required if the volume of VILTEPSO is 100 mL or more.
After preparation, VILTEPSO infusion
should begin as soon as possible
Infusion should begin no more than 5 hours after preparation of VILTEPSO and be completed within 6 hours of preparation (allowing for 1 hour of infusion time) if diluted solution is stored at 20°C to 26°C (68°F to 79°F).
VILTEPSO is administered via intravenous infusion using a peripheral or central venous catheter. Flush the intravenous access line with 0.9% sodium chloride for injection, USP, after infusion. Filtration of VILTEPSO is not required.
Do not mix other medications with VILTEPSO or infuse other medications concomitantly via the same intravenous access line.
VILTEPSO Pocket Dosing Guide
This guide serves as a quick reference for information on appropriate VILTEPSO dose and number of corresponding VILTEPSO vials, as well as corresponding volumes of saline, VILTEPSO, and total volume of VILTEPSO solution, for select patient body weights.
Product Order Form
Complete this form and fax or mail it to NS Support to order VILTEPSO for your appropriate patients with Duchenne muscular dystrophy (DMD) who are amenable to exon 53 skipping.
NS Pharma Goodwill Replacement Policy
Provides guidance on how to submit a request for replacement credit due to user error or technical malfunctions during the administration of VILTEPSO.
NS Pharma Return Goods Policy
Explains the requirements for initiating a VILTEPSO product return and describes which products are eligible for credit.
